Basic Information
Basic information for CT69-206-97aa
Peptide Name CT69-206-97aa
Genome Position chr6:134428587-134428877[-]
Species Human
Peptide Sequence MRTSVVLPDAWILPDLCFQSPSPQPGLCDASGLTDLRLGKDPSATCRQEKQRCPRQVQRSTDCVGLITLEEQKVLWLHKFEKQKVQSLYFWQTFQRL
Peptide Length 97
Unique No (CT69-201-97aa,CT69-203-97aa,CT69-208-97aa,CT69-210-97aa)
Grand Average of Hydropathicity -0.4495
Relative Molecular Mass 12950.59
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000231971;CT69
Transcript ID/Name ENST00000657570;CT69-206
Transcript Length 1559
Coding Ability 0.4054
DNA Sequence Corresponding to Peptide ATGAGAACCTCTGTGGTTCTTCCTGATGCTTGGATCCTCCCAGACCTCTGTTTCCAGTCTCCTTCTCCACAACCTGGCCTATGCGATGCAAGTGGTCTAACTGATCTCCGCCTAGGGAAGGATCCTTCGGCAACTTGCCGACAAGAGAAGCAGCGATGCCCGAGGCAGGTCCAAAGGAGCACTGACTGCGTGGGATTGATTACACTGGAGGAACAAAAGGTCCTGTGGCTACACAAGTTTGAAAAGCAGAAGGTACAATCATTGTATTTCTGGCAGACTTTTCAAAGACTT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :